Advanced THA Solution Features Tritanium Technology, Mako Robotics Compatibility to Boost Stability
Stryker, a global leader in medical technologies, launched the Trident II Acetabular System in India to advance total hip arthroplasty (THA) outcomes. This next-generation hip replacement platform delivers superior precision, stability, and surgeon confidence amid rising osteoarthritis cases and aging populations.
The Trident II builds on Stryker’s proven legacy, holding the distinction of the most implanted acetabular shell in the Australian Orthopaedic Association National Joint Replacement Registry for 20 consecutive years. It integrates cutting-edge Tritanium In-Growth Technology or PureFix HA for enhanced osseointegration, supporting diverse patient anatomies and surgical techniques.
Aman Rishi, Vice President & General Manager, India, Stryker, stated, “Hip replacement surgeries are rising globally due to ageing populations and rising incidence of osteoarthritis and mobility-related disorders. With the launch of the Trident II Acetabular System, we reinforce our commitment to bringing clinically proven, innovation-led solutions to surgeons and their patients. By combining advanced materials, data-backed design and robotic-arm assisted capabilities, Trident II represents a significant step forward in hip replacement solutions.”
Key features include compatibility with Mako SmartRobotics™ for precise implantation, the Innerchange Locking Mechanism for intraoperative flexibility with Modular Dual Mobility options to minimize dislocation risks, and X3 highly crosslinked polyethylene liners for superior wear resistance and oxidation stability.
This launch underscores Stryker’s focus on innovation-driven orthopaedics, equipping Indian surgeons with tools to optimize long-term THA success and patient mobility.